Stay updated on Faricimab in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Faricimab in Neovascular AMD Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page shows a site revision from v3.4.0 to v3.4.1. No changes to study content, eligibility criteria, or results are visible.
    Difference
    0.0%
    Check dated 2026-02-05T14:22:03.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Minor UI/metadata updates were applied, including enabling the glossary display and updating to revision v3.4.0, with removal of older QC status text and references to No FEAR Act data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-29T09:28:45.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 was removed. This update does not alter study details, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2026-01-14T03:15:31.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    - Added a new Locations section listing participating sites by country/region (US states and international sites) and updated the revision to v3.3.3. - Removed the prior per-location blocks from v3.3.2 in favor of the consolidated Locations listing.
    Difference
    2%
    Check dated 2025-12-23T17:29:46.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Publications section now clarifies that some results publications are provided voluntarily by the data submitter and that others are auto-filled from PubMed. The revision version was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:48:45.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    - The government's funding status notice has been removed from the page. The TENAYA trial details remain unaffected and continue to be presented.
    Difference
    0.1%
    Check dated 2025-11-17T19:59:05.000Z thumbnail image

Stay in the know with updates to Faricimab in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.